Antibody-drug conjugates are rapidly expanding cancer therapies, with 19 approved globally and many more in development, but ...
As of April 2025, four CD19-directed chimeric antigen receptor (CAR)-T therapies and three CD20-targeting bispecific antibodies (BsAbs) have been US Food and Drug Administration (FDA) approved for the ...
A research team led by a Duke professor recently developed a novel computational model to predict antibody structures, a significant breakthrough for disease prevention efforts. A study published in ...
Researchers have developed a novel antibody-based enzyme switch that converts antibody–antigen binding into enzyme activity, paving the way from detection via bioluminescence to the control of ...
SAN FRANCISCO -- There has been a lot of talk about testing for the coronavirus, but you may not entirely understand what the different tests are for. The coronavirus makes some people sick, some ...
– Collaboration leverages Cartography’s cutting-edge ATLAS and SUMMIT platforms to identify tumor-selective antigens; Pfizer to lead therapeutic development – – Cartography to receive upfront, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results